PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsRafa Laboratories
Rafa Laboratories
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AtropineAtropine2018-07-09
Uveitis
,
Diarrhea
,
Stomach ulcer
,
Bradycardia
,
Heart arrest
,
Poisoning
,
Sinoatrial block
,
Drug-induced abnormalities
,
Pain
,
Drug overdose
MidazolamMidazolam2022-08-082028-2038
Psychomotor agitation
,
Status epilepticus
,
Anxiety disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Midazolam
healthy volunteers/patients
,
melanoma
,
neoplasms
,
muscular atrophy
,
spinal muscular atrophy
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
developmental disabilities
,
mental disorders
,
neurodevelopmental disorders
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
breast neoplasms
Midazolam maleate
healthy volunteers/patients
,
melanoma
,
neoplasms
,
muscular atrophy
,
spinal muscular atrophy
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
developmental disabilities
,
mental disorders
,
neurodevelopmental disorders
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
breast neoplasms
Midazolam hydrochloride
healthy volunteers/patients
,
melanoma
,
neoplasms
,
muscular atrophy
,
spinal muscular atrophy
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
developmental disabilities
,
mental disorders
,
neurodevelopmental disorders
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
breast neoplasms
Benzodiazepine
healthy volunteers/patients
,
type 2 diabetes mellitus
,
neoplasms
,
melanoma
,
overweight
,
non-small-cell lung carcinoma
,
obesity
,
respiratory syncytial virus infections
,
brain neoplasms
,
central nervous system neoplasms
,
brain diseases
,
glucose metabolism disorders
,
metabolic diseases
,
alzheimer disease
,
huntington disease
,
thyroid neoplasms
,
glioma
,
sickle cell anemia
,
atopic dermatitis
,
colorectal neoplasms
,
anxiety disorders
,
prostatic neoplasms
,
breast neoplasms
,
liposarcoma
,
adenocarcinoma of lung
,
generalized anxiety disorder
,
reflex epilepsy
,
bipolar disorder
,
diabetes mellitus
,
epilepsy
,
status epilepticus
,
critical illness
,
delirium
,
psychomotor agitation
,
post-traumatic stress disorders
,
executive function
,
seizures
,
partial epilepsies
,
generalized epilepsy
,
complex partial epilepsy
,
schizophrenia
,
insulin resistance
,
metabolic syndrome
,
syndrome
,
major depressive disorder
,
depressive disorder
,
psychotic disorders
,
gastrointestinal endoscopy
,
hyperlipidemias
,
hyperglycemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use